Bi 456906, structural properties and pharmacology of the novel glucagon and glucagon-like peptide-1 receptor (GCGR/GLP-1R) dual agonist

被引：0
作者：
Augustin, R. [1 ]
Zimmermann, T. [1 ]
Thomas, L. [1 ]
Baader-Pagler, T. [1 ]
Haebel, P. [1 ]
Simon, E. [1 ]
Klein, H. [1 ]
Santhanam, R. [1 ]
Reindl, W. [1 ]
Bajrami, B. [1 ]
Rist, W. [1 ]
Uphues, I. [1 ]
Hamprecht, D. [2 ]
Neubauer, H. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[2] Pharmaxis Ltd, Frenchs Forest, NSW, Australia
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
570
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [31] Glucagon-Like Peptide-1 Receptor: A Novel Receptor in Platelets
    Kahal, Hassan
    Aburima, Ahmed
    Spurgeon, Benjamin
    Wraith, Katie S.
    Ghavideldarestani, Maryam
    Rizvi, Faran
    Sturmey, Roger G.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    Naseem, Khalid M.
    [J]. DIABETES, 2015, 64 : A528 - A528
  • [32] Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)
    Mendez, Maria
    Matter, Hans
    Defossa, Elisabeth
    Kurz, Michael
    Lebreton, Sylvain
    Li, Ziyu
    Lohmann, Matthias
    Loehn, Matthias
    Mors, Hartmut
    Podeschwa, Michael
    Rackelmann, Nils
    Riedel, Jens
    Safar, Pavel
    Thorpe, David S.
    Schaeffer, Matthias
    Weitz, Dietmar
    Breitschopf, Kristin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2292 - 2307
  • [33] Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
    Ussher, John R.
    Reggio, Laurie L.
    Campbell, Jonathan E.
    Mulvihill, Erin E.
    Kim, Minsuk
    Kabir, M. Golam
    Cao, Xiemin
    Beranek, Benjamin M.
    Stoffers, Doris A.
    Seeley, Randy J.
    Drucker, Daniel J.
    [J]. MOLECULAR METABOLISM, 2014, 3 (05): : 507 - 517
  • [34] Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function
    Koole, Cassandra
    Wootten, Denise
    Simms, John
    Savage, Emilia E.
    Miller, Laurence J.
    Christopoulos, Arthur
    Sexton, Patrick M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (06) : 3659 - 3673
  • [35] Insulin dose adjustments with add-on glucagon-like peptide-1 receptor (GLP-1R) agonists in clinical practice
    Artigas, Carla Frances
    Stokes, Victoria
    Tan, Garry D.
    Theodorakis, Michael J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (10) : 1417 - 1421
  • [36] The Role of Endogenous Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling in Respiratory Syncytial Virus (RSV) Infection
    Wu, Ashley
    Ceneviva, Zachary
    Peebles, Stokes
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB12 - AB12
  • [37] GABAA receptor-mediated currents in the hippocampus are transiently enhanced by glucagon-like peptide-1 receptor (GLP-1R) agonists
    Korol, S. V.
    Jin, Z.
    Babateen, O.
    Birnir, B.
    [J]. ACTA PHYSIOLOGICA, 2014, 211 : 83 - 83
  • [38] Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
    Mabilleau, Guillaume
    Pereira, Marie
    Chenu, Chantal
    [J]. JOURNAL OF ENDOCRINOLOGY, 2018, 236 (01) : R29 - R42
  • [39] A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon-like peptide-1 receptor agonist, in healthy Japanese men with overweight/obesity
    Yazawa, Rie
    Ishida, Masahiro
    Balavarca, Yesilda
    Hennige, Anita M.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (07) : 1973 - 1984
  • [40] Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1655 - 1661
12345